DD

Dipti Dadasaheb Jagadale

Active Director Director DIN 10762031
DIN 10762031 First appointment Aug 2024 Primary industry Veterinary
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Dipti Dadasaheb Jagadale

Data last updated:

Dipti Dadasaheb Jagadale is a Director at Tejomay Dnyan Foundation (since 2024). The company operates in Veterinary.

DIN 10762031
Primary Designation Director
Industry Veterinary
First Appointment 30 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Tejomay Dnyan Foundation U85211PN2024NPL233979
Director30 Aug 20242024Active

Directorship timeline

Open interactive timeline →
Tejomay Dnyan Foundation
Premium access

Shareholding and investment profile for Dipti Dadasaheb Jagadale

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dipti Dadasaheb Jagadale

Dipti Dadasaheb Jagadale currently holds 1 directorship: Tejomay Dnyan Foundation (Director, since 30 Aug 2024).

Dipti Dadasaheb Jagadale was first appointed on 30 Aug 2024 as Director at Tejomay Dnyan Foundation.

The current boards of Dipti Dadasaheb Jagadale's companies include Apurva Ashok Palande (Tejomay Dnyan Foundation), Bhagyashri Sanjay Raut (Tejomay Dnyan Foundation), Digvijay Ashok Palande (Tejomay Dnyan Foundation), Prafull Dattatray Palande (Tejomay Dnyan Foundation), Pranit Hemant Dhawale (Tejomay Dnyan Foundation).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available